Labcorp Perspectives: Oncology

Labcorp

Country USA

Genres Health & Fitness, Science, Medicine

Language EN

Episodes 13

Latest 20.07.2026

Explore the ever-evolving world of cancer care in our insightful content series, Labcorp Perspectives as we delve into the latest advancements in oncology diagnostics and their impact on patient outcomes. Each episode brings together leading oncology experts to discuss groundbreaking research, practical applications, and real-world challenges. More than just information, this series fosters collaboration and unbiased education, empowering healthcare professionals, researchers, and patients to stay informed and at the forefront of medical oncology.

Episodes

How SLICE is Speeding Up Cancer Treatment Decisions 20.07.2026 33m

Discover how SLICE enables rapid, personalized drug testing on live tumors to help oncologists pick the best treatments for cancer patients.
How Molecular Profiling is Changing Cancer Grading 05.06.2026 20m

Discover how molecular profiling and pathology grading intersect to improve endometrial cancer diagnosis and drive better outcomes.
Advancing Endometrial Cancer Care with Molecular Profiling 15.05.2026 32m

How molecular profiling of GOG258 is changing advanced endometrial cancer care—insights on POL-E, prognosis, and precision treatment.
The Pulse of the Oncologist: Listening to What Matters Most 15.04.2026 22m

Pulse of the Oncologist survey reveals trends in cancer diagnostics, digital solutions, care barriers, and the innovations transforming oncology today.
Navigating the Future of CDXs in Oncology 19.02.2026 26m

CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.
FFPE: The Workhorse Behind NGS Testing 29.01.2026 33m

Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.
ctDNA Breakthroughs in Mesothelioma Care 04.11.2025 15m

Exploring immunotherapy and ctDNA innovation in mesothelioma, where molecular monitoring may redefine early cancer detection and treatment.
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy 20.10.2025 26m

Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.
Redefining Ovarian Cancer Care with Biomarkers 08.09.2025 14m

Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.
Why Comprehensive Testing Matters—Ken Schlosser’s Lung Cancer Story 01.08.2025 23m

Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.
Rethinking How We Track and Treat Cancer 14.07.2025 19m

HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.
Tumor-Agnostic Therapies and the Future of HER2 in Oncology 09.06.2025 20m

What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.
Why Genetic Testing Should Be Standard in Prostate Cancer 19.05.2025 19m

Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.